Screener
Insmed INSM Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 83.5%+7.7pp | 81.8%+5.3pp | 79.7%+3.3pp | 76.5%-0.7pp | 75.7%-1.9pp | |
| Operating margin | -73.9%+179pp | -140.6%+117pp | -205.6%+35.9pp | -258.9%-18.0pp | -252.4%-21.0pp | |
| Net margin | -76.9%+183pp | -144.4%+121pp | -210.5%+40.7pp | -264.8%-12.8pp | -259.8%-15.5pp | |
| Returns | ||||||
| Return on equity | -87.2%+73.3pp | -294.5%— | -249.3%— | -165.7%— | -160.5%— | |
| Return on invested capital | -126.1%+239pp | -149.4%+48.9pp | -146.6%-8.5pp | -104.8%+9.7pp | -365.2%-10.2pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×+0.3× | 0.4×+0.2× | 0.3×+0.1× | 0.2×0.0× | 0.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.7×-3.0× | 4.5×-1.4× | 3.8×-1.6× | 4.6×-1.7× | 6.7×+4.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.3× | 0.8×-10.7× | 0.8×-3.2× | 0.6×-1.5× | 0.5×-30.9× | |
| Per Share | ||||||
| Book value per share | $3.49-47.2% | $3.27+497% | $3.71+113% | $4.47+60.5% | $6.60+2,531% | |
| Valuation | ||||||
| Market capitalization | $21.94B-36.9% | $35.25B+155% | $37.12B+201% | $30.44B+170% | $20.12B+102% | |
| Price / sales | 19.3×-58.5× | 43×+6.8× | 61.2×+27.2× | 68.1×+35.2× | 50.5×+20.3× | |
| Price / book | 29×-7.8× | 50×-89.2× | 50.2×+6.9× | 32.2×+8.8× | 16.1×-240× |
FAQ
- What are Insmed's profit margins?
- Insmed (INSM) runs a 83.5% gross margin and a -73.9% operating margin, with a -76.9% net margin.
- Where do Insmed's ratios come from?
- Every ratio is computed from Insmed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
